Literature DB >> 11287605

Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter.

T Yoshikawa1, H Shimano, M Amemiya-Kudo, N Yahagi, A H Hasty, T Matsuzaka, H Okazaki, Y Tamura, Y Iizuka, K Ohashi, J Osuga, K Harada, T Gotoda, S Kimura, S Ishibashi, N Yamada.   

Abstract

In an attempt to identify transcription factors which activate sterol-regulatory element-binding protein 1c (SREBP-1c) transcription, we screened an expression cDNA library from adipose tissue of SREBP-1 knockout mice using a reporter gene containing the 2.6-kb mouse SREBP-1 gene promoter. We cloned and identified the oxysterol receptors liver X receptor (LXRalpha) and LXRbeta as strong activators of the mouse SREBP-1c promoter. In the transfection studies, expression of either LXRalpha or -beta activated the SREBP-1c promoter-luciferase gene in a dose-dependent manner. Deletion and mutation studies, as well as gel mobility shift assays, located an LXR response element complex consisting of two new LXR-binding motifs which showed high similarity to an LXR response element recently found in the ABC1 gene promoter, a reverse cholesterol transporter. Addition of an LXR ligand, 22(R)-hydroxycholesterol, increased the promoter activity. Coexpression of retinoid X receptor (RXR), a heterodimeric partner, and its ligand 9-cis-retinoic acid also synergistically activated the SREBP-1c promoter. In HepG2 cells, SREBP-1c mRNA and precursor protein levels were induced by treatment with 22(R)-hydroxycholesterol and 9-cis-retinoic acid, confirming that endogenous LXR-RXR activation can induce endogenous SREBP-1c expression. The activation of SREBP-1c by LXR is associated with a slight increase in nuclear SREBP-1c, resulting in activation of the gene for fatty acid synthase, one of its downstream genes, as measured by the luciferase assay. These data demonstrate that LXR-RXR can modify the expression of genes for lipogenic enzymes by regulating SREBP-1c expression, providing a novel link between fatty acid and cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287605      PMCID: PMC86928          DOI: 10.1128/MCB.21.9.2991-3000.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

Review 2.  A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 3.  Dietary regulation of gene expression: enzymes involved in carbohydrate and lipid metabolism.

Authors:  A G Goodridge
Journal:  Annu Rev Nutr       Date:  1987       Impact factor: 11.848

4.  ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation.

Authors:  P Tontonoz; J B Kim; R A Graves; B M Spiegelman
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

5.  Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene.

Authors:  M Amemiya-Kudo; H Shimano; T Yoshikawa; N Yahagi; A H Hasty; H Okazaki; Y Tamura; F Shionoiri; Y Iizuka; K Ohashi; J Osuga; K Harada; T Gotoda; R Sato; S Kimura; S Ishibashi; N Yamada
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

6.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene.

Authors:  C Yokoyama; X Wang; M R Briggs; A Admon; J Wu; X Hua; J L Goldstein; M S Brown
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme.

Authors:  S Andersson; D L Davis; H Dahlbäck; H Jörnvall; D W Russell
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

8.  Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization.

Authors:  X Wang; M R Briggs; X Hua; C Yokoyama; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

9.  Sterol-resistant transcription in CHO cells caused by gene rearrangement that truncates SREBP-2.

Authors:  J Yang; R Sato; J L Goldstein; M S Brown
Journal:  Genes Dev       Date:  1994-08-15       Impact factor: 11.361

10.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element.

Authors:  X Hua; C Yokoyama; J Wu; M R Briggs; M S Brown; J L Goldstein; X Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

View more
  147 in total

1.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

2.  Liver X receptor-α activation enhances cholesterol secretion in lactating mammary epithelium.

Authors:  Diego Y Grinman; Valeria P Careaga; Elizabeth A Wellberg; María V Dansey; Edith C Kordon; Steven M Anderson; Marta S Maier; Gerardo Burton; Paul S MacLean; Michael C Rudolph; Adali Pecci
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-04-09       Impact factor: 4.310

3.  Quantitative proteomic profiling reveals hepatic lipogenesis and liver X receptor activation in the PANDER transgenic model.

Authors:  Mark G Athanason; Whitney A Ratliff; Dale Chaput; Catherine B MarElia; Melanie N Kuehl; Stanley M Stevens; Brant R Burkhardt
Journal:  Mol Cell Endocrinol       Date:  2016-07-07       Impact factor: 4.102

4.  Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.

Authors:  Xue-Qing Zhang; Orli Even-Or; Xiaoyang Xu; Mariska van Rosmalen; Lucas Lim; Suresh Gadde; Omid C Farokhzad; Edward A Fisher
Journal:  Adv Healthc Mater       Date:  2014-08-22       Impact factor: 9.933

5.  Importance of LXR-alpha transcriptome in the modulation of innate immunity.

Authors:  Deepak Kaul; Ankur Gautam; Kavleen Sikand
Journal:  Mol Cell Biochem       Date:  2006-06-07       Impact factor: 3.396

Review 6.  Liver X receptors as therapeutic targets in metabolism and atherosclerosis.

Authors:  Takashi Nomiyama; Dennis Bruemmer
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

7.  Common and Differential Transcriptional Actions of Nuclear Receptors Liver X Receptors α and β in Macrophages.

Authors:  Ana Ramón-Vázquez; Juan Vladimir de la Rosa; Carlos Tabraue; Felix Lopez; Bonifacio Nicolas Díaz-Chico; Lisardo Bosca; Peter Tontonoz; Susana Alemany; Antonio Castrillo
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

8.  Restoration of sterol-regulatory-element-binding protein-1c gene expression in HepG2 cells by peroxisome-proliferator-activated receptor-gamma co-activator-1alpha.

Authors:  Hannes Oberkofler; Elisabeth Schraml; Franz Krempler; Wolfgang Patsch
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

9.  Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.

Authors:  Yun Sok Lee; Hyoung Ho Lee; Jiyoung Park; Eung Jae Yoo; Carlotta A Glackin; Young Il Choi; Sung Ho Jeon; Rho Hyun Seong; Sang Dai Park; Jae Bum Kim
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

10.  Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression.

Authors:  Rex A Parker; Ricardo Garcia; Carol S Ryan; Xiaoqin Liu; Petia Shipkova; Valentin Livanov; Pritesh Patel; Siew P Ho
Journal:  J Lipid Res       Date:  2013-04-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.